Remove tag white-papers
article thumbnail

Valentine’s Day Food Offers from Popeyes, Cinnabon and More

XTalks

The Classic includes one appetizer (think Spinach Artichoke Dip, White Corn Guacamole and Chips, or Mexican Street Corn), a pair of entrees (pizzas, pastas and salads are on the roster), and a dessert (Red Velvet Cake, Key Lime Pie or Butter Cake) for $40. White Castle. Hancock Gourmet Lobster Co.

article thumbnail

How data is crucial to the relaunch of the Cancer Moonshot

pharmaphorum

During the first stage of the initiative, more than 2,000 research papers were published, 49 clinical trials were carried out, and more than 30 patents were filed through the support of the US National Cancer Institute (NCI). These datasets are critical as a means to identify how molecular information affects clinical outcomes.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Risk sharing agreements soar as market access risk increases

Pharmaceutical Technology

In some cases, she said, “[drug] innovation would have been otherwise hindered by their price tag alone”. Watt explained that for newer, first-in-class drugs these types of agreements can also give healthcare systems safety in their decisions to approve certain drugs. Click here to watch this webinar and access the presentation.

Marketing 257
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. Novo Nordisk is another company leading the charge in this field. In a Phase II study, CagriSema achieved a numerically higher body weight reduction of 15.6% compared to a 5.1%

Drugs 264
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. Novo Nordisk is another company leading the charge in this field. In a Phase II study, CagriSema achieved a numerically higher body weight reduction of 15.6% compared to a 5.1%

Drugs 246